The reduction in DNMT1 activity by inhibiting GSK3β-mediated phosphorylation of DNMT1 resulted in the re-expression of hormone receptors AR and ER in PCa and BCa cells, respectively, and re-sensitized these cancers to antihormones. Here, ESR1 is linked to cancer.